This invention relates to the field of biologically active compounds and specifically to novel ansamitocin derivatives, pharmaceutical compositions comprising these novel ansamitocin derivatives, methods for the production of the ansamitocin derivatives of the general formula (I):
and their use for the treatment of cancer.
本发明涉及
生物活性化合物领域,具体涉及新型ansamitocin衍
生物,包括这些新型ansamitocin衍
生物的制药组合物,制备ansamitocin衍
生物的方法,以及它们用于治疗癌症的用途。